TY - JOUR
T1 - In vitro activity of HSR-903, a new oral quinolone, against bacteria causing respiratory infections
AU - Watanabe, Akira
AU - Tokue, Yutaka
AU - Takahashi, Hiroshi
AU - Kikuchi, Tohru
AU - Kobayashi, Takao
AU - Gomi, Kazunori
AU - Fujimura, Shigeru
AU - Nukiwa, Toshihiro
PY - 1999/7
Y1 - 1999/7
N2 - The in vitro activity of HSR-903, an oral quinolone, against 196 recent clinical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against Staphylococcus aureus, including methicillin-resistant strains, and Streptococcus pneumoniae and was at least as active as the other quinolones against gram-negative pathogens.
AB - The in vitro activity of HSR-903, an oral quinolone, against 196 recent clinical isolates of respiratory pathogens was evaluated. HSR-903 was 2 to 32 times more active than ofloxacin, ciprofloxacin, and sparfloxacin against Staphylococcus aureus, including methicillin-resistant strains, and Streptococcus pneumoniae and was at least as active as the other quinolones against gram-negative pathogens.
UR - http://www.scopus.com/inward/record.url?scp=0032789383&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032789383&partnerID=8YFLogxK
U2 - 10.1128/aac.43.7.1767
DO - 10.1128/aac.43.7.1767
M3 - Article
C2 - 10390240
AN - SCOPUS:0032789383
SN - 0066-4804
VL - 43
SP - 1767
EP - 1768
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 7
ER -
